Back to Search
MICHAEL POLIS, M.D.
M.D.
Infectious Disease Physician
NPI: 1821316704Individual
Specialties, Licenses & Credentials
Infectious Disease PhysicianPrimary
Internal Medicine — Infectious Disease
Code: 207RI0200X
D0028336(MD)
Research & Publications (20)
Suppression of cerebrospinal fluid HIV burden in antiretroviral naive patients on a potent four-drug antiretroviral regimen.
PMID 12819518·AIDS·2003
3-trial
Correlation between reduction in plasma HIV-1 RNA concentration 1 week after start of antiretroviral treatment and longer-term efficacy.
PMID 11734232·Lancet·2001
8-other
Association of interleukin-15-induced peripheral immune activation with hepatic stellate cell activation in persons coinfected with hepatitis C virus and HIV.
PMID 19594300·J Infect Dis·2009
8-other
Human immunodeficiency virus and hepatitis C infections induce distinct immunologic imprints in peripheral mononuclear cells.
PMID 19551908·Hepatology·2009
8-other
Identification and characterization of CRF02_AG, CRF06_cpx, and CRF09_cpx recombinant subtypes in Mali, West Africa.
PMID 19182920·AIDS Res Hum Retroviruses·2009
8-other
Rapid development of advanced liver fibrosis after acquisition of hepatitis C infection during primary HIV infection.
PMID 19519227·AIDS Patient Care STDS·2009
5-case
Idiopathic CD4+ lymphocytopenia: natural history and prognostic factors.
PMID 18456875·Blood·2008
4-observational
Identification of novel markers for liver fibrosis in HIV/hepatitis C virus coinfected individuals using genomics-based approach.
PMID 18614866·AIDS·2008
4-observational
Frequent polymorphism at drug resistance sites in HIV-1 protease and reverse transcriptase.
PMID 18301062·AIDS·2008
4-observational
Immunodeficiency and intrinsic IFN resistance are associated with viral breakthrough to HCV therapy in HIV-coinfected patients.
PMID 18184077·AIDS Res Hum Retroviruses·2007
8-other
ART suppresses plasma HIV-1 RNA to a stable set point predicted by pretherapy viremia.
PMID 17411338·PLoS Pathog·2007
3-trial
Comparison of the abbott 7000 and bayer 340 systems for measurement of hepatitis C virus load.
PMID 17596352·J Clin Microbiol·2007
4-observational
Differential antiviral effect of PEG-interferon-alpha-2b on HIV and HCV in the treatment of HIV/HCV co-infected patients.
PMID 17721093·AIDS·2007
8-other
Predictors for hematopoietic growth factors use in HIV/HCV-coinfected patients treated with peginterferon alfa 2b and ribavirin.
PMID 16987047·AIDS Patient Care STDS·2006
3-trial
Fluorodeoxyglucose imaging in healthy subjects with HIV infection: impact of disease stage and therapy on pattern of nodal activation.
PMID 16603850·AIDS·2006
8-other
Fluorodeoxyglucose imaging in healthy subjects with HIV infection: impact of disease stage and therapy on pattern of nodal activation.
PMID 16470113·AIDS·2006
8-other
Naïve T-cell dynamics in human immunodeficiency virus type 1 infection: effects of highly active antiretroviral therapy provide insights into the mechanisms of naive T-cell depletion.
PMID 16501076·J Virol·2006
8-other
Gene expression profiles in hepatitis C virus (HCV) and HIV coinfection: class prediction analyses before treatment predict the outcome of anti-HCV therapy among HIV-coinfected persons.
PMID 16544259·J Infect Dis·2006
4-observational
Hepatic histologic response (HR) to combination therapy among HCV/HIV-coinfected individuals: interferon induces HR independent of sustained virologic response (SVR).
PMID 17147494·AIDS Res Hum Retroviruses·2006
3-trial
Induction of prolonged survival of CD4+ T lymphocytes by intermittent IL-2 therapy in HIV-infected patients.
PMID 16025158·J Clin Invest·2005
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 10 CENTER DR, OP8 CLINIC, ROOM 8C402
BETHESDA, MD 20892 - Phone
- (301) 435-7743
Quick Facts
- NPI
- 1821316704
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile